540 related articles for article (PubMed ID: 24743428)
1. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.
Byrne CD; Targher G
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1155-61. PubMed ID: 24743428
[TBL] [Abstract][Full Text] [Related]
2. NAFLD: a multisystem disease.
Byrne CD; Targher G
J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
[TBL] [Abstract][Full Text] [Related]
3. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
Byrne CD
Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
[TBL] [Abstract][Full Text] [Related]
4. Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.
Targher G; Byrne CD
J Clin Endocrinol Metab; 2013 Feb; 98(2):483-95. PubMed ID: 23293330
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease and vascular risk.
Bhatia LS; Curzen NP; Byrne CD
Curr Opin Cardiol; 2012 Jul; 27(4):420-8. PubMed ID: 22596186
[TBL] [Abstract][Full Text] [Related]
6. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia LS; Curzen NP; Calder PC; Byrne CD
Eur Heart J; 2012 May; 33(10):1190-200. PubMed ID: 22408036
[TBL] [Abstract][Full Text] [Related]
8. Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?
Ahmed MH; Byrne CD
Drug Discov Today; 2010 Aug; 15(15-16):590-5. PubMed ID: 20601094
[TBL] [Abstract][Full Text] [Related]
9. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
Byrne CD
Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
[TBL] [Abstract][Full Text] [Related]
10. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.
Asrih M; Jornayvaz FR
J Endocrinol; 2013 Sep; 218(3):R25-36. PubMed ID: 23833274
[TBL] [Abstract][Full Text] [Related]
11. Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
Nestel PJ; Mensink RP
Curr Opin Lipidol; 2013 Feb; 24(1):1-3. PubMed ID: 23298957
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.
Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L
Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277
[TBL] [Abstract][Full Text] [Related]
13. Recent concepts in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease and cardiovascular risk.
Brea A; Puzo J
Int J Cardiol; 2013 Aug; 167(4):1109-17. PubMed ID: 23141876
[TBL] [Abstract][Full Text] [Related]
15. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
Santos RD; Valenti L; Romeo S
Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
[TBL] [Abstract][Full Text] [Related]
16. [Non-alcoholic fatty liver disease: a new challenge for cardiologists].
Tarquini R; Lazzeri C; Boddi M; Marra F; Abbate R; Gensini GF
G Ital Cardiol (Rome); 2010 Sep; 11(9):660-9. PubMed ID: 21348181
[TBL] [Abstract][Full Text] [Related]
17. Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease.
Yang J; Guan Y
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():105-11. PubMed ID: 23855304
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside.
Gariani K; Philippe J; Jornayvaz FR
Diabetes Metab; 2013 Feb; 39(1):16-26. PubMed ID: 23266468
[TBL] [Abstract][Full Text] [Related]
19. Current treatment of non-alcoholic fatty liver disease.
Ahmed MH; Byrne CD
Diabetes Obes Metab; 2009 Mar; 11(3):188-95. PubMed ID: 18564173
[TBL] [Abstract][Full Text] [Related]
20. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
Tilg H; Moschen A
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]